BriaCell Therapeutics Corp.

4.64 USD
-0.08 (-1.69%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

BriaCell Therapeutics Corp. stock is up 17.77% since 30 days ago. The next earnings date is Dec 22, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 46.15% of the previous 13 December’s closed higher than November.

About BriaCell Therapeutics Corp.

BriaCell Therapeutics Corp. engages in developing immunotherapies for the treatment of cancer. Lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors. Company also has a cooperative research and development agreement with the National Cancer Institute.